There have been several publications recently in which the part played by mycoplasmas in human disease [1] and, particularly, in genitourinary disease [2] [3] [4] has been reviewed. In this communication the role of mycoplasmas in the etiology of non-gonococcal urethritis (NGU) is discussed. OCCURRENCE OF MYCOPLASMAS IN THE GENITOURINARY TRACT Twelve mycoplasma species constitute the normal flora or are pathogens of humans. Nine of these mycoplasmas have been found in the respiratory tract and seven in the genitourinary tract (Table 1) , four having been isolated from both anatomical sites. Because Mycoplasma hominis and Ureaplasma urealyticum organisms (ureaplasmas) are found frequently in the genitourinary tract, especially in disease, they are the main mycoplasmal candidates for causing NGU.
CRITERIA FOR ESTABLISHING THAT A MYCOPLASMA IS A CAUSE OF DISEASE To establish a causal relationship between mycoplasmal infection and disease it is necessary to demonstrate that (i) the organisms are isolated more frequently and/or in larger numbers from patients with disease than from those without; (ii) antibody responses, measured by any of several available techniques, occur in patients with disease; (iii) the organisms disappear and the disease responds to treatment with antimicrobial agents to which the organisms are susceptible in vitro; and (iv) the organisms infect an animal host from which they can be recovered and, in so doing, produce disease similar to that seen in man; in other words, there should be fulfilment of Koch's postulates. 
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ROLE OF LARGE-COLONY-FORMING MYCOPLASMAS IN THE ETIOLOGY OF NGU Isolation Studies
After large-colony-forming mycoplasmas were first isolated from the male urethra, there have been numerous studies designed to determine whether they are a cause of NGU. The results of studies in which the frequency of isolation from men with NGU was compared with that from apparently healthy men have been summarized previously [5] . Although confusion may still exist about the interpretation of the various results, it is quite clear that M. fermentans and M. primatum cannot be considered as significant causes of NGU because they are isolated so rarely from the genitourinary tract in either health or disease. Most of the mycoplasmas, particularly in the early studies, were not identified, but it is likely that the majority of them were M. hominis. If this is so, when the studies are viewed as a whole, there is no difference between the frequency of isolation of this mycoplasma from men with disease and from apparently healthy men. However, if the studies are considered separately [6] , there are considerable differences in the results, probably because the criteria for selecting cases of NGU differed widely. These differences were supported by differences in the prevalence of complement-fixing antibody in the various groups [7] . This disparity in isolation rate and antibody prevalence between the NGU group and the so-called control group led to the belief that M. hominis was of etiological importance. However, when control groups more comparable to the patient group were studied, the difference in isolation rates was less apparent [2, 8, 9] . Indeed, some workers [10, 11] have isolated M. hominis more frequently from persons without urethritis than from those suffering from NGU. More recently, Bowie and colleagues [12, 13] examined patients without urethritis and those suffering from NGU, dividing the latter into chlamydia-positive and chlamydia-negative groups. M. hominis was isolated from the first-voided urine in 19-22 percent of men in all the groups, which did not lead these investigators to believe that it was a cause of disease. It is hardly surprising that interpretation of the results of most studies is difficult or impossible when the majority of workers have been unable or failed to take into account the possible role of other potential NGU-producing microorganisms, particularly chlamydiae.
Antibiotic Studies
The response of patients to antibiotics, including those which differentiate between M. hominis and some other microorganisms, has been difficult to interpret. Erythromycin was found to be effective in the treatment of NGU [14, 15] , although M. hominis is resistant to this antibiotic in vitro. This, however, does not mitigate against a role for M. hominis in NGU because the major clinical response may have been due to the effect of erythromycin on ureaplasmas and chlamydiae. In another study [16] , lincomycin, which inhibits M. hominis in vitro, was found to be more effective than a placebo in treating the disease but may also have inhibited chlamydiae which were not sought. Coufalik and colleagues [17] gave rifampicin, which is active against chlamydiae in vitro but ineffective against both M. hominis and ureaplasmas, to men who had NGU. Although the study was not designed to investigate whether M. hominis was pathogenic, the results were not consistent with this view. Undertaking a placebo-controlled antibiotic study in which only M. hominispositive NGU cases are included would seem to be the best approach to help support or refute this suggestion. ROLE OF UREAPLASMA UREAL YTICUM As mentioned previously, the problem in all studies concerned with the etiology of genitourinary diseases is that mycoplasmas are not the only contenders. Chlamydial infection causes probably 50 percent of cases of NGU, so that the question arises of whether ureaplasmal infection accounts for all, or part, of the remainder. The extent to which the requirements for incriminating a mycoplasma as a cause of disease have been fulfilled in the case of ureaplasmas and NGU is outlined in Table 2 . Some aspects which have not been helpful in defining this relationship have been discussed before [27] . It is worth drawing attention to two recent observations. The first concerns the detection of ureaplasmal antibody by an ELISA technique which has broad serotype cross-reactivity; a significant change in antibody levels for one or more antibody classes was detected in the sera of 12 (67 percent) of 18 NGU patients, and ten (83 percent) of the 12 individuals had a change in the IgM class suggestive of an active infection [20] . This was more than had been seen in previous studies where the metabolism-inhibition technique had often been used with a few serotypes only; because of its serotype specificity this procedure would not have been expected to detect more than a small proportion of responses, and IgM antibody would not have been sought. The second observation concerns ureaplasmal infection of the urethra of a 23-year-old hypogammaglobulinemic male patient [19] . He developed a chronic urethral discharge from which . 5 x 108 ureaplasmas, but not chlamydiae, were isolated. This is about 100-fold more than the number of ureaplasmas expected in men with urethritis, and in such profusion they were probably responsible for his disease. He did not respond clinically to any antibiotics since the organisms were resistant or developed resistance to all of them, including the tetracyclines.
It is clear from the data presented in Table 2 that most of the criteria required for regarding ureaplasmas as a cause of NGU have been met, and it does not seem reasonable to take the view that the results of all the studies are entirely false. It [4]
[181 [19] [4]
[20] [21] [22]
[23]
[17] [24] seems more rational to believe that the cumulative data are indicative of a pathogenic role for ureaplasmas in the male genital tract. Ureaplasmas in Men Who Do Not Have Urethritis If ureaplasmas are a cause of NGU, an explanation is required for their recovery so often from men who do not have urethritis. Several possibilities exist. It may be that (i) only certain ureaplasma serotypes are pathogenic. Serotype 4 was recovered in one study twice as frequently from men with NGU as from those who were symptom-free [21] . There may be grounds for believing, therefore, that serotypes are important but pathogenic and non-pathogenic strains could belong to a single serotype. (ii) Ureaplasmas involve only the prepuce and meatus in a non-diseaseproducing capacity but under some circumstances invade the urethra to cause NGU. Procedures have not, so far, distinguished between the different sites of colonization or infection in men with and without disease. (iii) Ureaplasmas produce NGU which resolves spontaneously, but the organisms then persist. (iv) Ureaplasmas produce NGU but those within the prostate and para-urethral glands are not always eliminated by treatment. These do not cause subsequent disease but are sometimes detected in the urethra. (v) Ureaplasmas cause only the first or early episodes of NGU, later encounters resulting in colonization without urethritis.
POST-GONOCOCCAL URETHRITIS (PGU)
PGU would seem to be caused mainly by chlamydiae [28] . Although there is evidence that ureaplasmas cause some cases of NGU, evidence that they cause any cases of PGU is lacking. The results of an early quantitative study [8] failed to suggest an association between ureaplasmas and PGU but could have been misleading because chlamydiae were not investigated. However, when these organisms were taken into account [29] an association was still not detected. In a study by Bowie and colleagues [30] , PGU was significantly associated with chlamydial infection (p < 0.02) among men who were not colonized by ureaplasmas; among men with chlamydial infections, PGU developed in 11 (61 percent) of 18 men who had a ureaplasmal infection and five (28 percent) of 18 who did not (p = 0.09). This may suggest that the ureaplasmas potentiated the chlamydial infections, but supportive data are required.
ROLE OF A NEWLY DISCOVERED MYCOPLASMA Some patients suffering from NGU, and from whom ureaplasmas, mycoplasmas, and chlamydiae cannot be isolated, respond to tetracycline therapy. This has suggested that another tetracycline-sensitive microorganism might be responsible for these cases. In this context, the isolation of a glucose-metabolizing mycoplasma from the genitourinary tract of two of 13 men with NGU by means of a special culture medium (SP4) is of interest [31, 32] . The strains G37 and M30 are closely related to each other and are different serologically from all other known mycoplasmas, thus constituting a new species which has been named M. genitalium [33] . The organisms adhere to glass and plastic, erythrocytes, and monkey kidney cells. This property appears to be associated with surface material restricted to the area of a terminal structure of the flask-shaped mycoplasmas. Although there are insufficient data to relate this new mycoplasma to NGU or other genitourinary infections, its isolation in special medium, specialized structure, capacity to adhere to cells, and ability to produce an inflammatory cell response in the vagina of marmosets, accompanied by an antibody response [34] indicate that it has pathogenic potential; its presence in the urethra of patients with NGU suggests that it could be implicated in the disease.
CONCLUSIONS AND PROPOSALS The overall impression is that M. hominis is not a cause of NGU. However, subsequent to the isolation of U. urealyticum, this large-colony-forming mycoplasma has been almost totally ignored. It may be prudent to consider it as a candidate for causing some cases of NGU because of its known ability to cause postpartum and postabortal fever and acute salpingitis. The relevance of studies based on differential antibiotic therapy undertaken so far is dubious. They would be unlikely to lead to the recognition of a small contribution by M. hominis, particularly as chlamydiae were not taken into consideration. The best approach would be to design a study in which a group of NGU patients infected with M. hominis and ureaplasmas but not chlamydiae were treated with lincomycin, an inhibitor of M. hominis but not ureaplasmas, and a similar group of patients were treated with erythromycin, which has the reverse effect. Further approaches worthy of consideration in evaluating a possible role of M. hominis in NGU are serological evaluations based, particularly, on the ELISA technique, and experimental intraurethral inoculation of male chimpanzees with strains, possibly those that have spread hematogenously, which have had few passes in medium.
It is not possible to predict which of the explanations, if any, for ureaplasmas occurring in men without urethritis is most likely to be correct and, of course, they may not be mutually exclusive. It is clear, however, that studies should be designed to resolve the situation and that these must take into account all potential pathogenic microorganisms, not just ureaplasmas, and be quantitative rather than qualitative in nature. In the meantime, it is important to emphasize that there is no virtue in attempting to isolate ureaplasmas from patients with NGU on a routine basis since positive results, so easy to obtain, do not enable the clinician to know whether the organisms are unequivocally a cause of the diseases.
In the case of M. genitalium, efforts to define its distribution and relation to disease are in progress. A study of experimentally inoculated marmosets revealed that serum antibody was best detected by an immunofluorescence technique. It is clear that this technique, among others, should be used in attempts to detect antibody responses in men with NGU. Furthermore, although the pathogenicity of this mycoplasma has been demonstrated in female marmosets, the relevance of the microorganism to NGU would be better satisfied by undertaking studies in male chimpanzees.
